EFIS is a non-profit umbrella organisation that represents 36 European immunology societies. Via funding initiatives and awards, EFIS helps to support immunological research and education and strengthens scientific interaction via study groups, task forces and its triennial congress - the European Congress of Immunology (ECI).
EFIS is a non-profit umbrella organisation that represents 36 immunology societies in Europe. Via funding initiatives and awards, EFIS helps to support immunological research and education and strengthens scientific interaction via study groups, task forces and its triennial congress - the ECI.
4 Oct 2024
2025 - 2027 EFIS Board
Congratulations are in order for the members of the newly elected EFIS Board!
4 Oct 2024
2025 EFIS Eastern Star Awards
The call for applications for the 2025 EFIS Eastern Star Awards, addressed to Eastern European laboratories, will be launched on 1 October 2024.
14 Aug 2024
The 2024 EJI Ita Askonas Prize Awarded by EFIS
On the recommendation of its Gender & Diversity Task Force, EFIS is delighted to announce Dr. Sarina Ravens, Hannover Medical School, as the recipient of the 2024 EJI Ita Askonas Prize awarded by EFIS.
View all news
At the EFIS General Assembly held during the 2024 ECI in Dublin, the new EFIS Board was elected. Continue reading to learn more about them.
Find out more
4 Oct 2024
Issue Information: Eur. J. Immunol. 10'24
4 Oct 2024
Cover Story: Eur. J. Immunol. 10'24
4 Oct 2024
Impressum
2 Oct 2024
A20 intrinsically influences human effector T‐cell survival and function by regulating both NF‐κB and JNK signaling
30 Sept 2024
Liver type 1 innate lymphoid cells undergo apoptosis in murine models of macrophage activation syndrome and are dispensable for disease
Unfolding the symbiosis of AID, chromatin remodelers, and epigenetics–The ACE phenomenon of antibody diversity
Mucosal associated invariant T cells: Powerhouses of the lung
Single-cell sequencing has revealed a more complex array of thymic epithelial cells
Pancreatic ductal adenocarcinoma microenvironment: Soluble factors and cancer associated fibroblasts as modulators of NK cell functions
Proteasome isoforms in human thymi and mouse models
